31 results
424B3
ALLR
Allarity Therapeutics Inc
7 Jun 22
Prospectus supplement
5:26pm
result, including:
regulatory authorities may withdraw approvals of such drugs;
we may be required to recall a drug or change the way such a drug … letters;
withdrawal of the drugs from the market;
refusal to approve pending applications or supplements to approved applications that we submit;
recall
POS AM
ALLR
Allarity Therapeutics Inc
2 Jun 22
Prospectus update (post-effective amendment)
7:58pm
;
we may be required to recall a drug or change the way such a drug is administered to patients;
additional restrictions may be imposed … applications or supplements to approved applications that we submit;
recall of drugs;
fines, restitution or disgorgement of profits or revenues
10-K
2021 FY
EX-10.19
ALLR
Allarity Therapeutics Inc
16 May 22
Annual report
7:12pm
in writing, if it obtains information indicating that any Product may be subject to any recall, corrective action, or other regulatory action by any
10-K
2021 FY
ALLR
Allarity Therapeutics Inc
16 May 22
Annual report
7:12pm
and reporting obligations, contractual damages, reputational harm, diminished profits and future earnings, injunctions, requests for recall, seizure … result, including:
regulatory authorities may withdraw approvals of such drugs;
we may be required to recall a drug or change the way such a drug
10-K
EX-10.18
29ym7o 0yhxb0yu
16 May 22
Annual report
7:12pm
424B3
rgik5 5m2p7r6m
21 Dec 21
Prospectus supplement
5:01pm
424B3
bp6equ9fque131shq
5 Nov 21
Prospectus supplement
4:17pm